胃驻留
Search documents
快讯|荣耀明年将推出机器人手机;扫地机器人鼻祖 iRobot 资金濒临耗尽;深朴智能斩获2亿元融资等
机器人大讲堂· 2025-11-11 04:39
Group 1 - Honor Technology CEO Li Jian announced the launch of a ROBOT PHONE that integrates AI, embodied intelligence, and high-definition imaging, featuring a modular mechanical structure with a foldable and retractable design [2] - Honor plans to invest $10 billion over five years to build a leading global AI terminal ecosystem as part of its Alpha strategy [2] Group 2 - Simple AI, a new player in the embodied intelligence robotics sector, secured 200 million RMB in funding within three months, with investments from various venture capital firms [5] - The funds will be primarily used for the development of the robotic brain and body [5] Group 3 - iRobot, known as the pioneer of robotic vacuum cleaners, is facing a severe financial crisis, with cash reserves dwindling to below $25 million, down from over $40 million in the previous quarter [8] - The company is urgently seeking new financing or potential buyers to avoid bankruptcy [8] Group 4 - A research team from Zhejiang University and City University of Hong Kong developed a gastric retentive robotic capsule for emergency oral drug delivery, capable of remaining in the stomach for at least 10 weeks and releasing medication within 60 seconds [9] Group 5 - French startup NAAREA partnered with Fluid Wire Robotics to provide a robotic operating system for their next-generation XAMR micro-reactor, which can operate in extreme environments [10] - The XAMR reactor is designed to utilize long-lived nuclear waste while generating 40 MW of electricity and 80 MW of high-temperature heat [10]
Science子刊:南科望/于欣格合作开发胃驻留、智能响应机器人胶囊,破解应急口服给药难题
生物世界· 2025-11-02 02:25
编辑丨王多鱼 排版丨水成文 口服给药因无创、易操作、患者接受度高的特性,是临床及日常健康管理中应用最广泛的给药方式,尤其 在需长期用药或不便开展专业医疗操作的场景中,更是保障治疗连续性的关键。 在急性医疗场景中,传统口服给药依赖患者自主吞咽能力,而注射等侵入性方式需专业操作,两者均难以 满足突发状况下的时效性与安全性需求。 野外人员、认知障碍者等群体,常因药物获取难、无法自主服药 等问题延误救治;精神病患者给药时还可能危及自身与他人安全。虽有无人机递送、生物传感器植入等应 急给药方案,但均不兼容口服制剂,且存在需手术植入、药物储存不安全等弊端。紧急口服给药系统需满 足一键 / 自动激活、 60 秒内完全释药、体内储药等核心需求,现有技术难以兼顾。这些痛点凸显了研发 适配口服制剂的应急响应药物系统的迫切性。 近日, 浙江大学药学院 南科望 研究员 与香港城市大学 于欣格 教授 团队合作 ( 浙江大学化工学院博士 研究生 黄浩 、浙江大学药学院博士后 樊云龙 为论文共同第一作者 ) ,在 Science 子刊 Science Advances 上发表了题为: A gastric retentive robotic ...